SYN•benzinga•
Synthetic Biologics has received a Notice of Allowance for its US patent application 17/314,583 titled 'E. COLI-BASED PRODUCTION OF BETA-LACTAMASE (FOR MICROBIOME-PROTECTING THERAPY)'. Recent reverse split. - PatentGrants
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga